Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 496

1.

Breast tumor copy number aberration phenotypes and genomic instability.

Fridlyand J, Snijders AM, Ylstra B, Li H, Olshen A, Segraves R, Dairkee S, Tokuyasu T, Ljung BM, Jain AN, McLennan J, Ziegler J, Chin K, Devries S, Feiler H, Gray JW, Waldman F, Pinkel D, Albertson DG.

BMC Cancer. 2006 Apr 18;6:96.

2.

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.

Bergamaschi A, Kim YH, Wang P, Sørlie T, Hernandez-Boussard T, Lonning PE, Tibshirani R, Børresen-Dale AL, Pollack JR.

Genes Chromosomes Cancer. 2006 Nov;45(11):1033-40.

PMID:
16897746
3.

Clinical array-based karyotyping of breast cancer with equivocal HER2 status resolves gene copy number and reveals chromosome 17 complexity.

Gunn S, Yeh IT, Lytvak I, Tirtorahardjo B, Dzidic N, Zadeh S, Kim J, McCaskill C, Lim L, Gorre M, Mohammed M.

BMC Cancer. 2010 Jul 28;10:396. doi: 10.1186/1471-2407-10-396.

4.

High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization.

Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, Zaks TZ, Weber BL.

Breast Cancer Res. 2005;7(6):R1186-98. Epub 2005 Nov 24.

5.

Integration of transcript expression, copy number and LOH analysis of infiltrating ductal carcinoma of the breast.

Hawthorn L, Luce J, Stein L, Rothschild J.

BMC Cancer. 2010 Aug 27;10:460. doi: 10.1186/1471-2407-10-460.

6.

Global search for chromosomal abnormalities in infiltrating ductal carcinoma of the breast using array-comparative genomic hybridization.

Somiari SB, Shriver CD, He J, Parikh K, Jordan R, Hooke J, Hu H, Deyarmin B, Lubert S, Malicki L, Heckman C, Somiari RI.

Cancer Genet Cytogenet. 2004 Dec;155(2):108-18.

PMID:
15571796
7.

Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH.

Joosse SA, Brandwijk KI, Devilee P, Wesseling J, Hogervorst FB, Verhoef S, Nederlof PM.

Breast Cancer Res Treat. 2012 Apr;132(2):379-89. doi: 10.1007/s10549-010-1016-7. Epub 2010 Jul 8.

PMID:
20614180
8.
9.

High-resolution genomic and expression analyses of copy number alterations in breast tumors.

Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, Lohr S, Wu TD, Cavet G, Zhang Z, Chant J.

Genes Chromosomes Cancer. 2008 Jun;47(6):530-42. doi: 10.1002/gcc.20558.

PMID:
18335499
10.

Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.

Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL.

Cancer Res. 2004 Dec 1;64(23):8541-9.

11.

DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.

Han W, Jung EM, Cho J, Lee JW, Hwang KT, Yang SJ, Kang JJ, Bae JY, Jeon YK, Park IA, Nicolau M, Jeffrey SS, Noh DY.

Genes Chromosomes Cancer. 2008 Jun;47(6):490-9. doi: 10.1002/gcc.20550.

PMID:
18314908
12.
13.

Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.

Melchor L, Honrado E, García MJ, Alvarez S, Palacios J, Osorio A, Nathanson KL, Benítez J.

Oncogene. 2008 May 15;27(22):3165-75. Epub 2007 Dec 10.

PMID:
18071313
14.

Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.

Malamou-Mitsi VD, Syrrou M, Georgiou I, Pagoulatos G, Agnantis NJ.

J Exp Clin Cancer Res. 1999 Sep;18(3):357-61.

PMID:
10606182
15.

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.

Missiaglia E, Selfe J, Hamdi M, Williamson D, Schaaf G, Fang C, Koster J, Summersgill B, Messahel B, Versteeg R, Pritchard-Jones K, Kool M, Shipley J.

Genes Chromosomes Cancer. 2009 Jun;48(6):455-67. doi: 10.1002/gcc.20655.

PMID:
19235922
16.

Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma.

Parris TZ, Danielsson A, Nemes S, Kovács A, Delle U, Fallenius G, Möllerström E, Karlsson P, Helou K.

Clin Cancer Res. 2010 Aug 1;16(15):3860-74. doi: 10.1158/1078-0432.CCR-10-0889. Epub 2010 Jun 15.

17.

Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.

Kloth JN, Oosting J, van Wezel T, Szuhai K, Knijnenburg J, Gorter A, Kenter GG, Fleuren GJ, Jordanova ES.

BMC Genomics. 2007 Feb 20;8:53.

18.

Micro-scale genomic DNA copy number aberrations as another means of mutagenesis in breast cancer.

Chao HH, He X, Parker JS, Zhao W, Perou CM.

PLoS One. 2012;7(12):e51719. doi: 10.1371/journal.pone.0051719. Epub 2012 Dec 17.

19.

Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.

Jönsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR, Greshock JD, Luts L, Olsson H, Rahman N, Stratton M, Ringnér M, Borg A, Weber BL.

Cancer Res. 2005 Sep 1;65(17):7612-21.

20.

Identification of candidate genes associated with salivary adenoid cystic carcinomas using combined comparative genomic hybridization and oligonucleotide microarray analyses.

Kasamatsu A, Endo Y, Uzawa K, Nakashima D, Koike H, Hashitani S, Numata T, Urade M, Tanzawa H.

Int J Biochem Cell Biol. 2005 Sep;37(9):1869-80.

PMID:
15908262

Supplemental Content

Support Center